Barrett Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Barrett Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,900	Closed	-$62K	–	411
2017 Q3	$62K	Hold	4,900	–	–	﹤0.01%	220
2017 Q2	$58K	Hold	4,900	–	–	﹤0.01%	234
2017 Q1	$72K	Hold	4,900	–	–	0.01%	203
2016 Q4	$79K	Hold	4,900	–	–	0.01%	196
2016 Q3	$89K	Hold	4,900	–	–	0.01%	184
2016 Q2	$81K	Hold	4,900	–	–	0.01%	189
2016 Q1	$81K	Buy	4,900 +800	+20%	+$14K	0.01%	181
2015 Q4	$89K	Buy	4,100 +3,850	+1,540%	+$74.9K	0.01%	173
2015 Q3	$5K	Buy	+250	New	+$7.9K	﹤0.01%	296

Other funds holding HZNP

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barrett Asset Management's HZNP Position: Q4 2017 in Review

Barrett Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2017, closing a stake of 4,900 shares — an estimated $62K sold.

Barrett Asset Management first reported a position in HZNP in Q3 2015 and held it in 9 quarters. The position peaked at $89K in Q3 2016. 183 funds tracked by Wall St. Rank hold HZNP as of Q4 2017.

Barrett Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2017 after selling out during the quarter.
Barrett Asset Management sold 4,900 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2017, an estimated $62K.
Barrett Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 9 quarters.
Barrett Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $89K in Q3 2016.
183 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2017.

Based on Barrett Asset Management's 13F filing for Q4 2017, filed 7 Feb 2018.